On the recordMarch 18, 2013
Additionally, the U.S. bio-pharmaceutical industry has had several patents disregarded, just disregarded, due to inappropriate use of compulsory licensing and patent revocation.
Source
congress.govAdditionally, the U.S. bio-pharmaceutical industry has had several patents disregarded, just disregarded, due to inappropriate use of compulsory licensing and patent revocation.
Carper highlights issues with patent rights for U.S. bio-pharmaceuticals in India.
Share
More from Tom Carper
I felt forever that there's actually revenues opportunities for the Postal Service through vote by mail.
I think the greatest way that the Commission can have an impact on that is probably through our rate-making authority.
We will do it again. Maybe the next time we will actually make it to Columbia.
We are better off when we hear community concerns at the beginning of the process rather than at the end.